Charco Neurotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.24M

  • Investors
  • 18

Charco Neurotech General Information

Description

Developer of health care devices designed to help people with Parkinson's disease and improve their quality of life. The company develops a non-invasive wearable device that modulates sensory dysfunction, enabling people with Parkinson's disease to improve their movement speed while living a normal life.

Contact Information

Formerly Known As
TheMoment
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wellington House
  • East Road
  • Cambridge CB1 1BH
  • England, United Kingdom
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Other Healthcare Technology Systems
Corporate Office
  • Wellington House
  • East Road
  • Cambridge CB1 1BH
  • England, United Kingdom

Charco Neurotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Charco Neurotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Seed Round 27-Jun-2024 $6.24M Completed Generating Revenue
12. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
11. Accelerator/Incubator 01-Apr-2022 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Seed Round 06-Oct-2021 Completed Generating Revenue
8. Seed Round 29-Dec-2020 Completed Generating Revenue
7. Accelerator/Incubator 23-Nov-2020 Completed Startup
6. Accelerator/Incubator 08-Sep-2020 Completed Startup
5. Angel (individual) 28-Oct-2019 $123K $149K Completed Startup
4. Equity Crowdfunding 21-Oct-2019 $25.3K $25.3K Completed Startup
To view Charco Neurotech’s complete valuation and funding history, request access »

Charco Neurotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Shares
Seed Shares
Ordinary
Ordinary 90,756 $0.000013 $0.35 $0.35 1x $0.35 1.23%
Ordinary 94,645 $0.000013 $0.98 $0.98 1x $0.98 1.29%
To view Charco Neurotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Charco Neurotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of health care devices designed to help people with Parkinson's disease and improve their quality of life. The
Therapeutic Devices
Cambridge, United Kingdom
43 As of 2023

San Mateo, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Charco Neurotech Competitors (2)

One of Charco Neurotech’s 2 competitors is Cala Health, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cala Health Venture Capital-Backed San Mateo, CA
Encora Therapeutics Venture Capital-Backed Boston, MA
You’re viewing 2 of 2 competitors. Get the full list »

Charco Neurotech Patents

Charco Neurotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202407178-D0 Strap arrangement for use with wearable devices for mitigating symptoms of neurological conditions of users Inactive 20-May-2024
GB-202307526-D0 Strap arrangement for use with wearable devices for mitigating symptoms of neurological conditions of users Pending 19-May-2023
GB-2630139-A Strap arrangement for use with wearable devices for mitigating symptoms of neurological conditions of users Pending 19-May-2023
JP-2026530922-A Wearable device for alleviating symptoms of a user's neurological condition and method of using the same Pending 19-May-2023
EP-4712846-A1 Wearable device for mitigating symptoms of neurological conditions of users and method for using same Pending 19-May-2023 A61B5/4836
To view Charco Neurotech’s complete patent history, request access »

Charco Neurotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Charco Neurotech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Angels Angel Group Minority
Grow London Accelerator/Incubator
Innovate UK Government
Imperial College London University Minority
The University of Tokyo Edge Capital Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Charco Neurotech FAQs

  • When was Charco Neurotech founded?

    Charco Neurotech was founded in 2019.

  • Where is Charco Neurotech headquartered?

    Charco Neurotech is headquartered in Cambridge, United Kingdom.

  • What is the size of Charco Neurotech?

    Charco Neurotech has 43 total employees.

  • What industry is Charco Neurotech in?

    Charco Neurotech’s primary industry is Therapeutic Devices.

  • Is Charco Neurotech a private or public company?

    Charco Neurotech is a Private company.

  • What is the current valuation of Charco Neurotech?

    The current valuation of Charco Neurotech is .

  • What is Charco Neurotech’s current revenue?

    The current revenue for Charco Neurotech is .

  • How much funding has Charco Neurotech raised over time?

    Charco Neurotech has raised $17.5M.

  • Who are Charco Neurotech’s investors?

    Cambridge Angels, Grow London, Innovate UK, Imperial College London, and The University of Tokyo Edge Capital are 5 of 18 investors who have invested in Charco Neurotech.

  • Who are Charco Neurotech’s competitors?

    Cala Health and Encora Therapeutics are competitors of Charco Neurotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process